The vector production facility produces lentivirus and retrovirus vectors in a sterile room, which is compliant with FDA's Current Good Laboratory Practice (GLP) and is used to produce viral vectors that support early clinical trials.https://www.creative-biolabs.com/immuno-oncology/virus-glp-production.htm
